PAA Stock: Financial Analysis and Stock Valuation: Plains All American Pipeline

0
143

Plains All American Pipeline, L.P. (NYSE:PAA) shares were trading higher by 1.61 percent ($0.38) at $23.96 a piece in Sunday’s session. It had closed the previous session at $23.58. PAA trades with a P/S ratio of 0.71. This is lower than the both industry’s 3.72 and the wider sector’s 14.57. A low price-to-sales ratio, typically less than 1.0, is considered a good value. Also, it has an estimated price-earnings (P/E) multiple of 15.93 and a trailing 12-month price-earnings (P/E) multiple of 27.73. Shares of PAA have uptrended 12.7% in the past three months, while the S&P 500 has moved 4.5% in that time. Plains All American Pipeline, L.P. (PAA) has a market cap of $17.42 billion and over the last 12 months, Plains All American Pipeline, L.P. (NYSE:PAA) has gone weaker by -23.96%. During the last 52 weeks, the (NYSE:PAA) price has been as high as $33.01 and as low as $18.38. Plains All American Pipeline, L.P. earnings have declined with an annualized rate of -29.3% over the last 5 years.

Plains All American Pipeline, L.P. (Mean Target Price: $24.64)The average 1-year price target for Plains All American Pipeline, L.P. (PAA) — averaging the work of different analysts — reveals a mean PT of $24.64/share. That’s a potential 2.84 increase relative to where Plains All American Pipeline, L.P. (NYSE:PAA) has been trading recently. The current price is seen ranging between $23.42 and $24.1. There are brokerage firms with lower targets than the average, including one setting a price target of $20. And then on the other side of the spectrum one analyst entrenched in the bullish camp has a target as high as $28.

Plains All American Pipeline, L.P. (PAA) Consensus RecommendationThe collective rating of 2.2 for Plains All American Pipeline, L.P. (NYSE:PAA) also leans strongly towards the neutral end of the spectrum. Of the 25 analysts surveyed by Reuters that track PAA 12 of them rate its stock a hold. The other 13, though not evenly; between analysts who think you should buy Plains All American Pipeline, L.P. versus those who think you should sell it. A 13 analysts rate it as either a buy or a strong buy, while0 believe that investors should either steer clear of PAA or, if they already own its stock, sell it.

Is NuVasive, Inc. (NASDAQ:NUVA) Cheap From Peers?NuVasive, Inc. (NUVA) pulled off a 1.6 percent gain and now trades for $53.33. NUVA comes in with a P/S ratio of 2.64 that’s greater than 1, potentially implying that it could be expensive relative to the overall sector (6.54) and its peers (7.55). Also, it has an estimated price-earnings (P/E) multiple of 23.15 and a trailing 12-month price-earnings (P/E) multiple of 44.85. During the last 52 weeks, the price has been as high as $81.68 and as low as $49.25. NuVasive, Inc. (NASDAQ:NUVA) earnings have risen with a quarterly rate of 12.2% over the last 5 years. Shares of NUVA have increased 4.4% in the past three monthswhile the S&P 500 has dropped -3.84% in that time.

NuVasive, Inc. (Price Objective: $71.47)NuVasive, Inc. (NASDAQ:NUVA) has a market cap of $2.71 billion and over the last 12 months, NUVA has declined by -23.69%. The average 1-year price target for (NUVA) reveals an average price target of $71.47 per share. That’s a potential 34.01 gain from where (NASDAQ:NUVA) has been trading recently. There are brokerage firms with lower targets than the average, including one setting a price target of $60. And then on the other side of the spectrum one analyst entrenched in the bullish camp has a target as high as $90.

Analyst Thoughts About NuVasive, Inc. (NASDAQ:NUVA)The consensus recommendation — averaging the work of 18 analysts — of 1.9 for NuVasive, Inc. (NUVA) points to bullish case. Of the analysts surveyed by Reuters that track NuVasive, Inc. 4 of them rate its stock a hold. The other 14 are split, though not evenly, between analysts who think you should buy its stock versus those who think you should sell it. A 14 analysts rate it as either a buy or a strong buy, while 0 believe that investors should either steer clear of (NASDAQ:NUVA) or, if they already own its stock, sell it.

LEAVE A REPLY

Please enter your comment!
Please enter your name here